Earnings: aTyr Pharma Losses Up $LIFE

aTyr Pharma, Inc., a bio-therapeutics company, has announce its first quarter results for FY-2015-16. The results shows Net Loss widens from -$6.093 Million to -$9.071 Million YoY, while cash and cash reserves increased from %15.853 Million to $54.512 Million quarterly. Yearly¬†Quarter Comparison Research & Development expenses Rise from $4.4 Million to $6.6 Million. General and …

Earnings: aTyr Pharma Losses Up $LIFE Read More »